Literature DB >> 24530030

1,2,3-triazole-, arylamino- and thio-substituted 1,4-naphthoquinones: potent antitumor activity, electrochemical aspects, and bioisosteric replacement of C-ring-modified lapachones.

Eduardo H G da Cruz1, Caio M B Hussene1, Gleiston G Dias1, Emilay B T Diogo1, Isadora M M de Melo1, Bernardo L Rodrigues1, Mauro G da Silva2, Wagner O Valença3, Celso A Camara3, Ronaldo N de Oliveira3, Yen G de Paiva4, Marilia O F Goulart4, Bruno C Cavalcanti5, Claudia Pessoa5, Eufrânio N da Silva Júnior6.   

Abstract

1,2,3-Triazole-, arylamino- and thio-substituted naphthoquinones (24, 8, and 2 representatives, respectively) were synthesized in moderate yields and evaluated against several human cancer cell lines (blood, ovarian, breast, central nervous system, colon, and prostate cancers and melanoma), showing, for some of them, IC50 values below 2 μM. The cytotoxic potential of the tested naphthoquinones was also assayed on non-tumor cells such as human peripheral blood mononucluear cells (PBMC) and two murine fibroblast lines (L929 and V79 cells). α-Lapachone- and nor-α-lapachone-based 1,2,3-triazoles and arylamino-substituted naphthoquinones showed potent cytotoxicity against different cancer cell lines. The compounds may represent promising new lead derivatives for anticancer drug development. The electrochemical properties of selected compounds were evaluated in an attempt to correlate them with antitumor activity.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1,2,3-Triazoles; 1,4-Naphthoquinone; Cancer; Click chemistry; Lapachol

Mesh:

Substances:

Year:  2014        PMID: 24530030     DOI: 10.1016/j.bmc.2014.01.033

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches.

Authors:  Lina S Prieto Cárdenas; Karen A Arias Soler; Diana L Nossa González; Wilson E Rozo Núñez; Agobardo Cárdenas-Chaparro; Pablo R Duchowicz; Jovanny A Gómez Castaño
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-31

2.  Design, Synthesis, and Biological Evaluation of Novel Fused Spiro-4H-Pyran Derivatives as Bacterial Biofilm Disruptor.

Authors:  Mohammad Irfan; Parvez Khan; Mohammad Abid; Md Musawwer Khan
Journal:  ACS Omega       Date:  2019-09-30

3.  Synthesis of Amino Acid-Naphthoquinones and In Vitro Studies on Cervical and Breast Cell Lines.

Authors:  Ernesto Rivera-Ávalos; Denisse de Loera; Jorge Gustavo Araujo-Huitrado; Ismailia Leilani Escalante-García; Miguel Antonio Muñoz-Sánchez; Hiram Hernández; Jesús Adrián López; Lluvia López
Journal:  Molecules       Date:  2019-11-25       Impact factor: 4.411

Review 4.  Hybrid Molecules Containing Naphthoquinone and Quinolinedione Scaffolds as Antineoplastic Agents.

Authors:  Ines Mancini; Jacopo Vigna; Denise Sighel; Andrea Defant
Journal:  Molecules       Date:  2022-08-03       Impact factor: 4.927

5.  Efficient Catalytic Oxidation of 3-Arylthio- and 3-Cyclohexylthio-lapachone Derivatives to New Sulfonyl Derivatives and Evaluation of Their Antibacterial Activities.

Authors:  Mariana F do C Cardoso; Ana T P C Gomes; Caroline Dos S Moreira; Mário M Q Simões; Maria G P M S Neves; David R da Rocha; Fernando de C da Silva; Catarina Moreirinha; Adelaide Almeida; Vitor F Ferreira; José A S Cavaleiro
Journal:  Molecules       Date:  2017-02-16       Impact factor: 4.927

6.  Synthesis and antitumor activity of selenium-containing quinone-based triazoles possessing two redox centres, and their mechanistic insights.

Authors:  Eduardo H G da Cruz; Molly A Silvers; Guilherme A M Jardim; Jarbas M Resende; Bruno C Cavalcanti; Igor S Bomfim; Claudia Pessoa; Carlos A de Simone; Giancarlo V Botteselle; Antonio L Braga; Divya K Nair; Irishi N N Namboothiri; David A Boothman; Eufrânio N da Silva Júnior
Journal:  Eur J Med Chem       Date:  2016-06-14       Impact factor: 6.514

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.